Transferrin (TF) is an 80 kDa iron-binding glycoprotein that plays essential roles in systemic and cellular iron homeostasis. In the nervous system, transferrin is critically important for delivering iron across the blood-brain barrier (BBB), distributing iron to neurons and glia, and maintaining iron balance in the brain. Iron dysregulation is a hallmark of numerous neurodegenerative diseases, making transferrin a protein of significant interest in neurobiology.
| Attribute | Value |
|-----------|-------|
| Protein Name | Transferrin |
| Gene | TF |
| UniProt ID | P02787 |
| PDB ID | 1BP5, 1JTF |
| Molecular Weight | ~80 kDa |
| Subcellular Localization | Secreted, extracellular |
| Protein Family | Transferrin family |
| Iron-binding capacity | 2 Fe³⁺ ions per molecule |
Transferrin is a single polypeptide chain of approximately 679 amino acids organized into two homologous lobes:
- N-lobe (N-terminal): Residues 1-339
- C-lobe (C-terminal): Residues 340-679
Each lobe contains:
- Iron-binding site: Conserved Asp-X-Ser-X-Arg-Lys motif
- Synaptic cleft: Opening for iron binding/release
- Inter-lobe bridge: Flexible hinge region connecting lobes
The crystal structure reveals a bilobal architecture with [1]:
- Two similar domains: Each lobe folds into two subdomains forming a cleft
- Iron coordination: Each iron is coordinated by four amino acids (two tyrosines, one aspartate, one histidine) plus a carbonate anion
- Conformational changes: Iron binding induces conformational closure of the cleft
- Two N-linked glycans: Located at Asn-413 and Asn-611
- Sialylation: Contributes to serum half-life and receptor recognition
- Structural role: Carbohydrate moieties stabilize the protein
The blood-brain barrier represents the primary interface for iron entry into the brain:
- Cellular pathway: Transferrin-bound iron enters brain endothelial cells via transferrin receptor-mediated endocytosis [2]
- Transcytosis: The transferrin-transferrin receptor complex undergoes transcytosis across endothelial cells
- Iron release: Endosomal acidification releases iron into the brain interstitial space
- CSF transferrin: The choroid plexus secretes transferrin into CSF, providing iron to brain cells [3]
- Local synthesis: Brain cells can produce transferrin for autocrine/paracrine signaling
- Iron homeostasis: CSF transferrin maintains brain iron balance under physiological conditions
Neurons obtain iron through multiple mechanisms:
- Transferrin receptor 1 (TfR1): High expression on neurons enables efficient iron uptake [4]
- Non-transferrin-bound iron (NTBI): Alternative iron source under certain conditions
- Ferritin internalization: Neurons can acquire iron through ferritin receptor-mediated endocytosis
Oligodendrocytes have particularly high iron requirements:
- Myelin production: Iron is essential for the metabolic processes supporting myelination [5]
- TfR1 expression: High expression enables substantial iron uptake
- Iron storage: Ferritin stores iron for ongoing myelin synthesis
¶ Astrocyte Iron Handling
Astrocytes play crucial roles in brain iron metabolism:
- Iron release: Can release stored iron through ferritin degradation
- Transferrin production: Astrocytes synthesize and secrete transferrin
- Neuronal support: Provide iron to neurons under various conditions
Iron accumulates in AD brain regions affected by pathology:
- Regional distribution: Increased iron in the hippocampus, basal forebrain, and cortex [6]
- Cellular localization: Iron co-localizes with amyloid plaques and neurofibrillary tangles
- Ferric iron (Fe³⁺): Predominant form associated with amyloid deposits
- Aβ-iron interaction: Amyloid-beta can bind iron, potentially facilitating its deposition [7]
- Redox cycling: Iron-Aβ complexes generate reactive oxygen species (ROS)
- Aggregated iron: Iron may accelerate Aβ aggregation
- Hyperphosphorylated tau: Iron accumulation correlates with tau pathology burden [8]
- Iron-induced phosphorylation: Iron can activate kinases that phosphorylate tau
- Neuronal vulnerability: Iron-loaded neurons show increased tau pathology
- Iron chelation: Desferrioxamine and other chelators have been investigated for AD treatment [9]
- Transferrin-based strategies: Enhancing brain iron export may offer therapeutic benefits
- BBB modulation: Improving transferrin receptor function could enhance iron clearance
The characteristic iron accumulation in PD provides insight into disease mechanisms:
- Regional specificity: Marked iron increase in substantia nigra pars compacta [10]
- Neuromelanin binding: Iron binds to neuromelanin in dopaminergic neurons
- Neuronal loss: Iron-loaded neurons are particularly vulnerable
- Oxidative stress: Iron catalyzes ROS formation, damaging dopaminergic neurons [11]
- Mitochondrial dysfunction: Iron accumulation impairs mitochondrial function
- Alpha-synuclein interaction: Iron may accelerate alpha-synuclein aggregation
- Iron chelation: Clioquinol and similar compounds have shown promise in clinical trials [12]
- Neuroprotective approaches: Modulating transferrin and iron metabolism
- Antioxidant therapy: Counteracting iron-induced oxidative damage
- Motor neuron vulnerability: Altered iron metabolism contributes to motor neuron death [13]
- Glial involvement: Astrocytes and microglia show abnormal iron handling
- Ferritin changes: Altered ferritin expression reflects iron dysregulation
- Iron chelation: Investigated for slowing disease progression
- Transferrin modulation: Targeting iron transport pathways
¶ Demyelination and Iron
- Lesion iron: MS lesions show iron accumulation in macrophages and microglia [14]
- Oligodendrocyte damage: Iron may contribute to oligodendrocyte death
- Remyelination: Iron is required for successful remyelination
- Iron chelation: Potential for reducing demyelination
- Oligodendrocyte support: Ensuring adequate iron for remyelination
- Striatal iron: Increased iron in the basal ganglia of HD patients [15]
- Cognitive correlation: Iron levels correlate with disease severity
- Mechanisms: Altered transferrin and ferritin expression
CSF transferrin and its isoforms serve as diagnostic markers:
- β-trace protein: Alternative name for CSF-specific transferrin
- ** isoform patterns**: Different glycoforms distinguish CSF from serum transferrin [16]
- BBB integrity: Transferrin isoform ratios indicate BBB breakdown
- Neurodegeneration: Altered CSF transferrin in AD, PD, and other conditions
- Demyelination: β-trace protein reductions indicate white matter damage
- Therapeutic monitoring: Tracking treatment response through transferrin levels
| Protein |
Role in Brain Iron Metabolism |
| Tf |
Transferrin - primary iron transporter |
| TfR1 |
Transferrin receptor - cellular uptake |
| DMT1 |
Divalent metal transporter - iron import |
| Ferritin |
Iron storage protein |
| FPN |
Ferroportin - iron export |
| [Hepcidin](/genes Hamp) |
Iron regulatory hormone |
Studying transferrin in neurodegeneration employs multiple approaches:
- Immunohistochemistry: Mapping transferrin distribution in brain tissue
- MRI imaging: Quantitative susceptibility mapping (QSM) for brain iron [17]
- CSF analysis: Measuring transferrin levels and isoforms
- Cell culture: Studying iron uptake in neurons and glia
- Animal models: Genetic and pharmacological manipulation
Several chelators have been investigated:
- Desferrioxamine (DFO): First-generation chelator; limited BBB penetration [18]
- Deferasirox: Oral chelator with better CNS penetration potential
- Clioquinol: Metal-protein attenuating compound with iron-chelating activity
- Novel agents: PBT2 and similar compounds in clinical development
- Transferrin conjugates: Targeting drugs to the brain via TfR1 [19]
- Engineered transferrin: Modified versions with enhanced brain delivery
- Gene therapy: Modulating transferrin expression
¶ Dietary and Lifestyle Interventions
- Iron supplementation: Careful balancing in aging and neurodegeneration
- Antioxidant support: Reducing iron-induced oxidative damage
- Lifestyle factors: Exercise and diet influence brain iron metabolism
Transferrin is essential for maintaining iron homeostasis in the brain, serving as the primary vehicle for iron transport across the blood-brain barrier and throughout the central nervous system. Iron dysregulation, mediated in part by altered transferrin function, contributes significantly to the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, MS, and Huntington's disease. Understanding transferrin's role in neurobiology offers multiple therapeutic opportunities, including iron chelation strategies, transferrin-based drug delivery, and modulation of brain iron metabolism.